House Foods Group (2810) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Jul, 2026Executive summary
Net sales for the nine months ended December 31, 2025, rose 1.1% year-over-year to ¥241,958 million, driven by price revisions and demand stimulation efforts.
Operating profit declined 15.6% year-over-year to ¥14,937 million as cost increases, especially for raw materials, outpaced the benefits of price hikes.
Ordinary profit and profit attributable to owners of parent also fell by 15.1% and 3.5% year-over-year, respectively.
The business environment was challenging due to inflation, rising costs, and consumer thriftiness.
Financial highlights
Gross profit increased slightly to ¥89,446 million, but selling, general, and administrative expenses rose 5.1% to ¥74,509 million.
Extraordinary income surged to ¥4,643 million, mainly from gains on sale of investment securities.
Profit per share (basic) was ¥126.57, down from ¥128.14 year-over-year.
Equity ratio remained strong at 67.4%, and net assets per share increased to ¥3,200.39.
Outlook and guidance
Full-year net sales forecast for FY2025 is ¥321,500 million (+1.9% year-over-year), with operating profit expected at ¥19,000 million (-5.0%).
Profit attributable to owners of parent is projected at ¥13,000 million (+4.1%), with no change to previously announced guidance.
Dividend forecast remains at ¥48.00 per share.
Latest events from House Foods Group
- Sales and operating profit rose, but net profit fell due to last year's one-time gain.2810
Q1 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on one-off factors; record profit targeted.2810
Q2 202513 Jul 2026 - Sales and operating profit increased, but net profit dropped sharply on one-time items.2810
Q4 202513 Jul 2026 - Sales and operating profit rose, but net profit fell on lower extraordinary gains; outlook unchanged.2810
Q3 202513 Jul 2026 - Profits fell on higher costs and weak demand, but stable dividends and a 2H recovery are forecast.2810
Q2 202613 Jul 2026 - Sales rose modestly, but profits fell sharply on higher costs; outlook and dividend unchanged.2810
Q1 202613 Jul 2026 - Profits fell on higher costs and U.S. impairments, but FY2027 profit set to rebound on asset sales.2810
Q4 202613 Jul 2026